Professional
Added to YB: 2024-08-29
Pitch date: 2024-08-28
SLP [bullish]
Simulations Plus, Inc.
-47.34%
current return
Author Info
No bio for this author
Company Info
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.
Market Cap
$516.5M
Pitch Price
$36.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
42.47
P/E
71.31
EV/Sales
6.31
Sector
Health Care Technology
Category
growth
Conestoga Capital Portfolio Holding: Simulations Plus, Inc.
SLP: FY2Q24 results beat estimates. Mgmt cautiously optimistic on improved pharma/biotech client funding. AI-integrated simulation software positions SLP as small-cap AI play. Strong financials & potential growth in AI-driven pharma tech sector.
Read full article (1 min)